StonvexLoading…
StonvexStonvexStonvexCore line items from SPSC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $192.12M | $751.50M | $558.85M | $368.95M |
Operating Income | $24.56M | $118.30M | $83.62M | $52.43M |
Net Income | $19.73M | $93.34M | $67.50M | $41.93M |
EPS (Diluted) | $0.53 | $2.46 | $1.77 | $1.10 |
Total Assets | $1.16B | $1.17B | $1.16B | $1.12B |
Total Liabilities | $199.05M | $195.97M | $199.74M | $171.32M |
Cash & Equivalents | $154.27M | $151.35M | $133.72M | $107.60M |
Free Cash Flow OCF − CapEx | $48.49M | $152.27M | $114.05M | $59.49M |
Shares Outstanding | 36.95M | 37.52M | 37.73M | 37.93M |